2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment

EP Europace ◽  
2021 ◽  
Author(s):  
Joshua Mbroh ◽  
Sven Poli
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Oral Anticoagulants ◽  
Heart Rhythm ◽  
Vitamin K Antagonist ◽  
Practical Guide

scholarly journals The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation

2018 ◽  
Vol 39 (16) ◽  
pp. 1330-1393 ◽  
Author(s):  
Jan Steffel ◽  
Peter Verhamme ◽  
Tatjana S Potpara ◽  
Pierre Albaladejo ◽  
Matthias Antz ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Oral Anticoagulants ◽  
Heart Rhythm ◽  
Vitamin K Antagonist ◽  
Practical Guide

scholarly journals The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary

EP Europace ◽  
2018 ◽  
Vol 20 (8) ◽  
pp. 1231-1242 ◽  
Author(s):  
Jan Steffel ◽  
Peter Verhamme ◽  
Tatjana S Potpara ◽  
Pierre Albaladejo ◽  
Matthias Antz ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Oral Anticoagulants ◽  
Heart Rhythm ◽  
Vitamin K Antagonist ◽  
Executive Summary ◽  
Practical Guide

scholarly journals Recommendations on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (Based on 2018 European Heart Rhythm Association Practical Guide)

Kardiologiia ◽  
2019 ◽  
Vol 59 (5) ◽  
pp. 68-79
Author(s):  
L. V. Popova ◽  
T. B. Kondratieva ◽  
M. B. Aksenova ◽  
T. V. Khlevchuk ◽  
M. Z. Kanevskaya
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Randomized Clinical Trials ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Heart Rhythm ◽  
Vitamin K Antagonist ◽  
Advanced Liver Disease ◽  
Clinical Variants

Non-vitamin K antagonist oral anticoagulants (NOACs) – direct oral anticoagulants – are getting the ever-broadening use in clinical practice. However, many problems related to optimal use of NOACs in specific clinical situations remain unresolved. European Heart Rhythm Association in April 2018 issued the renovated recommendations on the use of NOACs in patients with atrial fibrillation. The authors of recommendations presented some specific clinical variants for which they formulated practical advices based on the evidence obtained in randomized clinical trials. They also outlined the indications for use of NOACs, formulated practical start-program and scheme of subsequent follow-up management of patients taking NOACs. Recommendations contain information on pharmacokinetics of NOACs and their interactions with other drugs, consideration of feasibility of NOACs use in patients with chronic renal insufficiency or advanced liver disease. Many other practical problems are covered as well.  

scholarly journals Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

EP Europace ◽  
2015 ◽  
Vol 17 (10) ◽  
pp. 1467-1507 ◽  
Author(s):  
Hein Heidbuchel ◽  
Peter Verhamme ◽  
Marco Alings ◽  
Matthias Antz ◽  
Hans-Christoph Diener ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Vitamin K ◽  
Heart Rhythm ◽  
Vitamin K Antagonist ◽  
Practical Guide
Sign in / Sign up

Export Citation Format

Share Document